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A modiicação experimental para a síntese do MESG (2-amino-6-mercapto-7-metilpurina 
ribonucleosídeo) 1 foi realizada com sucesso e sua caracterização total apresentada. ESI(+)-MSMS 
em alta resolução foram realizados indicando que a clivagem nucleosídica como principal e um 
possível mecanismo SN1. Cálculos ab initio baseados em estados de transição blueprint corroboram 
com a proposta de um mecanismo SN1 e descartam a possibilidade de um mecanismo SN2. Ensaios 
com a enzima purina nucleosídica fosforilase (PNP, tanto humana como de M. tuberculosis) 
indicam a eiciência do substrato na reação de fosforilação do MESG e permitem a determinação 
de fosfato inorgânico em tempo real em ensaios biológicos. 
A modiied experimental procedure for the synthesis of MESG (2-amino-6-mercapto-7-
methylpurine ribonucleoside) 1 has been successfully performed and its full characterization is 
presented. High resolution ESI(+)-MSMS indicates both the nucleoside bond cleavage as the 
main fragmentation in the gas phase and a possible SN1 mechanism. Ab initio transition state 
calculations based on the blue print transition state support this mechanistic rationale and discard 
an alternative SN2 mechanism. Assays using purine nucleoside phosphorylase (PNP) enzyme 
(human and M. tuberculosis sources) indicate its eficiency in the phosphorolysis of MESG and 
allow the quantitative determination of inorganic phosphate in real time assay. 
Keywords: MESG, PNP enzyme, ESI, tuberculosis 
Introduction 
2-Amino-6-mercapto-7-methylpurine ribonucleoside 
1 (MESG) is a very important substrate for the continuous 
spectrophotometric assay of inorganic phosphate and 
for measuring phosphate release kinetics in biological 
systems.1 In addition, 1 has been employed in the discovery 
of purine nucleoside phosphorylase (PNP) enzyme 
inhibitors.2 It has been established that this molecule 
is an important substrate for PNP and the kinetics of 
its phosphorolysis (or hydrolysis) can be conveniently 
followed spectrophotometrically in the range of 355-360 nm 
(Scheme 1).3 The PNP-catalyzed phosphorolysis of the 
guanosine analogue MESG (λ
max
 = 330 nm at pH 7.6) 
releases the free base 2-amino-6-mercapto-7-methylpurine 
2 (λ
max
 = 360 nm at pH 7.6). 1 has also been used to monitor 
the activities of several ATPases.4 
PNP is an enzyme of great importance and plays a 
role in clinical medicine,5 especially because this enzyme 
is associated with profound immunodeiciency in T-cell 
function.6,7 Further interest in this enzyme has signiicantly 
increased since the discovery that the congenital absence 
of its activity causes T-cell impairment in human beings, 
though keeping normal levels of B-cells.8 Human PNP 
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is therefore a target for the development of drugs to treat 
immunological disorders, such as rheumatoid arthritis, 
psoriasis, inflammatory bowel disorders and multiple 
sclerosis, and T-cell proliferative disorders, such as organ 
transplant rejection, T-cell lymphoma and T-cell leukemia.
Hence, an eficient and appropriate methodology for 
synthesis and characterization of 1 is essential to our 
research interests in biological systems.9-13 A previously 
described synthesis of this compound is found in the 
literature14 although the old methodology employed has 
inherent technical problems. Furthermore, it is surprising 
that for this important substrate, its physical-chemical 
properties have hitherto not been described. Based on our 
interest in the study of PNP enzymes15 and in the chemistry 
of biologically active compounds,16-19 we describe herein an 
adapted synthesis and full spectroscopic characterization 
of 1. An insight into the phosphorolysis mechanism is also 
discussed based on electrospray ionization (tandem) mass 
spectrometry analysis.
Experimental
General
All chemicals were purchased from commercial sources. 
All calculations were carried out using Gaussian 98, with 
optimization using ab initio RHF calculation with basis 
sets 3-21G and 6-31G**. The transition state calculations, 
assuming an SN2 (irst) and an SN1 (latter) mechanisms, 
were carried out with the same basis and using a QST2 
optimization. Both MESG isomers (basic pH tautomer and 
acidic pH tautomer, see Scheme 1) were considered, as 
well as the corresponding free-base isomers. ESI mass and 
tandem mass spectra in positive ion modes were acquired 
using a Micromass (Manchester-UK) QTof instrument of 
ESI-QqTof coniguration with 7.000 mass resolving power 
in the TOF mass analyzer. The following typical operating 
conditions were used: 3kV capillary voltage, 20 V cone 
voltage, and dessolvation gas temperature of 110 °C. 
General procedure to the synthesis of MESG 1
In a Fischer-Porter reactor, under argon atmosphere, 
2-amino-6-chloro-purine ribonucleoside (4.00 g, 
13.25 mmol) was dissolved in dry dimethylformamide 
(10 mL). Methyl iodide (4 mL, (9.12 g), 64.25 mmol) was 
added and the mixture was stirred overnight (T = 30 °C). 
Excess methyl iodide was removed under high vacuum. 
Part of the DMF is also removed during this procedure, 
but it guarantees the total removal of methyl iodide. 
Thiourea (2.00 g, 26.27 mmol) was added under an argon 
atmosphere and the mixture was stirred for an additional 
hour. Afterwards, pure dimethylamine was slowly added 
dropwise until the solution became neutral (naked eye 
observation by color change). This can also be tested with 
pH indicator paper, but was not necessary. The mixture 
was directly poured into stirred acetone (500 mL) to give 
a yellow precipitate. The solid was collected by iltration 
Scheme 1. Phosphorolysis of MESG 1 promoted by the PNP enzyme. 
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and dried in vacuum yielding compound 1 (4.73 g, 81%). 
Depending on the source of 2-amino-6-chloro-purine 
ribonucleoside, compound 1 was further chromatographed 
in silica eluted with ethyl acetate/1-propanol/water (5:2:1; 
v/v). The compound was dried to a yellow solid and stored 
desiccated at −80 °C. MESG can be stored at −80 °C over 
a long period. Decomposition occurs at room temperature. 
Solutions (water or commonly used buffers) are more stable 
than pure 1. The elemental analysis must be collected 
immediately after puriication. 1H NMR analysis was as 
expected. 13C NMR (APT) (DMSO-d6): d ppm 183.8, 162.4, 
159.7, 146.3, 118.3, 88.3, 85.6, 74.0, 69.5, 60.6, 36.8. FTIR 
(KBr, ν
max
/cm-1): 3338, 1603, 1540, 1260, 1041. Elemental 
Anal. Calc. for C11H16IN5O4S: C, 29.94; H, 3.65; N, 15.87. 
Found: C, 29.90; H, 3.55; N, 15.99.
Results and Discussion
The modiied synthesis of 1 (Scheme 2) was performed 
by addition of methyl iodide directly in a Fischer-Porter 
reactor, under an argon atmosphere, to 2-amino-6-chloro-
purine ribonucleoside, and stirred sealed overnight, 
affording the imidazolium intermediate. Untreated methyl 
iodide was removed under high vacuum. Thiourea was 
directly added in the reactor and the reaction mixture was 
stirred for an additional hour. The inconvenience of using 
“methanolic ammonia” from the original procedure14 can 
be avoided by direct dimethylamine addition dropwise 
until the solution became neutral. The acidity change is 
evident by color change (from yellow to light yellow) and 
was corroborated with pH indicator paper. Freshly formed 
compound 1 was then puriied and stored at −80 °C. 
The electrochemical behaviour of 1 was investigated by 
cyclic voltammetry. The cyclic voltammogram (CV) of 1 
is presented in Figure 1. 
Non-symmetric redox couples for well deined cathodic 
and anodic peaks are observed at –0.044 and 496 mV (vs. 
SCE), respectively. As the structure suggests, the reduction 
of 1 is facile mainly because of the presence of an iminium-
type nitrogen. The peak separation value observed during 
the charge transfer process (∆Ep) is 540 mV. The large 
difference observed in both charge transfer processes 
suggests a slow process at the surface of the platinum 
electrode. The current ratio of the anodic and cathodic peaks 
(Ipa/Ipc) is slightly smaller than unity (0.7), signifying that 
the electrochemical process is quasi-reversible. 
Scheme 2. Adapted MESG synthesis.
Figure 1. Cyclic voltammogram of compound 1 (1 mmol L−1 solution) 
in a 100 mmol L−1 solution of KCl (20 mL at pH 7.2) recorded at a scan 
rate of 20 mV s−1. 
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The enzymatic promoted phosphorolysis reaction of 1 
catalyzed by PNP may proceed through a transition state 
blueprint (Scheme 3), as previously proposed for inosine, 
the natural enzyme substrate, and recently reviewed.20 
It is possible to initiate a discussion whether the 
mechanism may proceed through an SN1 or SN2 mechanism 
for PNP substrates.21-23 A total inversion of the chiral 
centre in the ribose-1-phosphate product indicates an 
SN2 mechanism; however, many studies conducted by 
Schramm’s group indicate an SN1 mechanism. Based on 
our experience studying reaction mechanisms using mass 
spectrometry24 (including enzymatic biotransformation12 
study), we decided to perform a test to gain insight into the 
mechanism of the phosphorolysis reaction of 1 promoted 
by PNP enzyme by monitoring the chemically mimicked 
reaction by electrospray ionization mass spectrometry 
(ESI). When mixing inorganic phosphate and MESG 
(water solution), on-line electron ionization (tandem) mass 
spectrometry monitoring the high resolution ESI(+)-MS 
was recorded after 10 min of vortex stirring (Figure 2).
We can observe in Figure 2 (A) the presence of 1 (m/z 
314.0931), the free base (m/z 182), the protonated ribose-1-
phosphate and also a signal at m/z 133.0507. This signal was 
attributed to an oxonium cation derived from ribose moiety 
of 1, which is formed when mixing the reagents. Owing to 
the very low intensity of the signal, an ESI(+)-MSMS could 
not be recorded, but the high resolution mass points irmly 
to the online interception of the species. The ESI(+)-MSMS 
characterization of 1 (Figure 2, B) guarantees that the 
species is derived from the synthesized substrate. The mild 
transfer to the gas phase using ESI techniques indicates that 
Scheme 3. Proposed transition state blueprint for the phosphorolysis reaction of MESG 1. 
Figure 2. (A) High resolution ESI(+)-MS of MESG and inorganic 
phosphate in water. (B) ESI(+)-MSMS of pure MESG (m/z 314). 
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in fact, the mechanism of the phosphorolysis reaction may 
proceed through a SN1 pathway, as suggested by others.21 
According to the calculation results (supplementary 
information, Table S1), the basic pH tautomers are 
energetically more stable than the acidic pH tautomers. 
Taking the isolated molecules of reactants and products 
as reference, the calculated activation energies, regardless 
of the isomers or level of calculation, would be negative. 
Taking into account the molecules of reactants and products 
as being near to one another, which is more representative of 
the condensed phase, the effective activation energies would 
be approximately 100 kJ mol−1 in the RHF 3-21G level, and 
larger than 65 kJ mol−1 in the highest calculation level (RHF 
6-31G**), which indicate that the SN2 mechanism, under 
these conditions, would be highly improbable. Indeed, it 
can be energetically discarded. The results clearly indicate 
that the SN1 pathway would be preferred. In fact, in the 
enzymatic environment, the idea of an SN1 mechanism is 
fairly plausible (Scheme 4, see supplementary information 
for the colour version). 
One further test was performed using freshly synthesized 
compound 1. An enzymatic assay promoted by human PNP 
accomplished the phosphorolysis reaction (Figure 3). When 
we used a Mycobacterium tuberculosis PNP source, similar 
results were obtained.
It is clear from the data displayed in Figure 3 that freshly 
synthesized compound 1 has a very good eficiency to be 
used as a biosensor for inorganic phosphate measurements 
by human PNP-catalyzed phosphorylase reaction. 
Reproducible data can be obtained after storing compound 
1 at very low temperatures (−80 °C) even after months of 
storage. 
Conclusions
In summary, we have described an improved and simple 
synthesis of MESG and its complete characterization. We 
have also demonstrated the value of mass spectrometry in 
furnishing mechanistic insights into important catalytic 
phosphorolysis reactions such as that of MESG. Our indings, 
supported by calculations, point to an SN1 mechanism 
instead of an SN2. Moreover, an improved synthesis and full 
characterization of MESG has been described.
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Table S1. MESG calculations energies
Structure 321G 631G**
1 MESG1 – 1387.3591 – 1394.9106
2 MESG2 – 1387.3892 – 1394.9176
3 PHOSPHATE (H2PO4–) – 637.9914 – 641.4856
4 (1+3) MESG1 + PHOSPHATE – 2025.3505 – 2036.3962
5 (2+3) MESG2 + PHOSPHATE – 2025.3806 – 2036.4032
6 REACTANTS 1 –2025.5167 –2036.5672
7 REACTANTS 2 – 2025.5711 – 2036.5594
8 TRANSITION STATE 1 – 2025.4802
9 TRANSITION STATE 2 – 2025.5258 – 2036.5340
Structure 321G 631G**
10 PRODUCTS 1 – 2025.5386 – 2036.5670
11 PRODUCTS 2 – 2025.5751 – 2036.5734
12 (14+16) FREE BASE 1 + RIB–1–P – 2025.5147 – 2036.5494
13 (15+16) FREE BASE 2 + RIB–1–P – 2025.5514 – 2036.5620
14 FREE BASE 1 (ch = 0) – 896.2612 – 901.0708
15 FREE BASE 2 (ch = 0) – 896.2979 – 901.0834
16 RIBOSE–1–PHOSPHATE – 1129.2535 – 1135.4786
17  (10–6) ∆HR1 (P–R)
– 0.0219
– 57.50kJmol–1
+ 0.0002
0.52 kJmol–1
18  (11–7) ∆HR2 (P–R)
– 0.004
– 10.50 kJmol–1
– 0.014
– 36.76 kJmol–1
19   (12–4) ∆HR1 (P–R) (isolated)
– 0.1642 
– 431.1 kJmol–1
– 0.1532
– 402.2 kJmol–1
20 (13–5) ∆HR2 (P–R) (isolated)
– 0.1708
– 448.4 kJmol–1
– 0.1588
– 416.9 kJmol–1
21 (8–4) EA1
– 0.1297
– 340.0kJmol–1
–
22 (9–5) EA2
– 0.1452
– 381.2kJmol–1
– 0.1308
– 343.4kJmol–1
23 (8–6) EA1’
+ 0.0365
+ 95.83kJmol–1
–
24 (9–7) EA2’
+ 0.0453
+118.9kJmol–1
+ 0.0254
+ 66.69kJmol–1
25    (1–2) ∆Hinterconversion, isol (R1–R2)
+ 0.0301
+ 79.0 kJmol–1
+ 0.007
+ 18.4 kJmol–1
26  (14–15) ∆Hinterconversion, isol (P1–P2)
+ 0.0367
+ 96.4 kJmol–1
+ 0.0126
+ 33.1 kJmol–1
27 FREE BASE 1 (ch = +1) – 896.6645 – 901.4640
28 FREE BASE 2 (ch = +1) –8 96.6966 – 901.4724
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Figure S1. High resolution ESI(+)MSMS
Figure S2. 13C NMR (APT) (DMSO-d6)
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Figure S3. FTIR (KBr, νmax/cm-1)
Figure S4. Calculated transition state
